Toggle light / dark theme

A new study of the genetic history of Sardinia, a Mediterranean island off the western coast of Italy, tells how genetic ancestry on the island was relatively stable through the end of the Bronze Age, even as mainland Europe saw new ancestries arrive. The study further details how the island’s genetic ancestry became more diverse and interconnected with the Mediterranean starting in the Iron Age, as Phoenician, Punic, and eventually Roman peoples began arriving to the island.

The research, published in Nature Communications, analyzed genome-wide DNA data for 70 individuals from more than 20 Sardinian archaeological sites spanning roughly 6,000 years from the Middle Neolithic through the Medieval period. No previous study has used genome-wide DNA extracted from ancient remains to look at the population history of Sardinia.

“Geneticists have been studying the people of Sardinia for a long time, but we haven’t known much about their past,” said the senior author John Novembre, Ph.D., a leading computational biologist at the Univeristy of Chicago who studies genetic diversity in natural populations. “There have been clues that Sardinia has a particularly interesting genetic history, and understanding this history could also have relevance to larger questions about the peopling of the Mediterranean.”

WASHINGTON — Lockheed Martin will acquire the satellite technology assets of Vector by default after a bankruptcy court received no qualified bids by a deadline last week.

In a Feb. 24 filing in the United States Bankruptcy Court for the District of Delaware, lawyers overseeing the bankruptcy proceedings for Vector said that they received no qualifying bids for the company’s GalacticSky software-defined spacecraft technology by a Feb. 21 deadline.

As a result, Lockheed Martin, which provided debtor-in-possession financing when Vector filed for Chapter 11 bankruptcy in December, will obtain the assets with a “stalking horse” bid of $4.25 million, according to the terms of a Jan. 24 filing. That deal will be finalized at a Feb. 28 court hearing.

Scientists in Australia are making some astonishing claims about a new nuclear reactor technology. Startup HB11, which spun out of the University of New South Wales, has applied for and received patents in the U.S., Japan, and China so far. The company’s technology uses lasers to trigger a nuclear fusion reaction in hydrogen and boron—purportedly with no radioactive fuel required. The secret is a cutting-edge laser and, well, an element of luck.

The laser doesn’t heat the materials. Instead, it speeds up the hydrogen to the point where it (hopefully) collides with the boron to begin a reaction.

Built on decades of previous research, a team from the University of Wisconsin-Madison teased out a tiny chunk of brain tissue within the thalamus, a nub above the brain stem, as a critical part of NCC. As proof of concept, they gave it several bouts of electrical shocks, and restored awareness in unconscious monkeys under heavy anesthesia.

The crux? As soon as the electrical stimulation stopped, the monkeys’ awareness also slipped away.

Although the thalamus has long been thought of as somehow involved in supporting consciousness, the study is one of the first to pinpoint exact neural circuits—highways between the thalamus and parts of the cortex—as “switches” for consciousness that we can control using brain stimulation. And that’s wonderful news for comatose patients.

If you can’t defeat death, what if you could postpone it, or at least postpone the diseases commonly associated with getting old?

Many people, especially the ultra-wealthy in Silicon Valley, are investing money into companies trying to answer exactly those questions.

Amazon CEO Jeff Bezos and billionaire PayPal co-founder Peter Thiel have both invested in South San Francisco-based Unity Biotechnology, a company whose mission is to “extend human healthspan, the period in one’s life unburdened by the disease of aging.”